Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by bigdog343on Jun 12, 2020 1:11pm
270 Views
Post# 31144104

RE:RE:Waiting for Godot?

RE:RE:Waiting for Godot?
lonc17 wrote: I have been invested in this company for twenty years.  There has always been a very slight possiblity of partnership or buyout.  Every year the liklihood decreases but it is still above zero.  And the potential payout is such that I may get at least half my money back, despite being down more than 90% at this time (based on average cost over many years of buying).  

I cannot possibly sell.  It would be terrible to sell after twenty years and then see the buyout one month later!

So I'm stuck with a crappy company that has terrible management and few legitimate prospects.  I'm sure this happens all the time.


Can't you just write off the loss?   No one is ever married to a stock as when its time to dump we do it and move on.     I will hold til end of year then if they still are increasing shares will move on.  Eventually they will do another RS and will spin it anyway they want. Such as many other companies do.  

Bullboard Posts